Globe Newswire 8-Jul 10:18 PM
Array BioPharma Announces Interim Analysis Results from the BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer
PRNewswire 6-Jul 5:20 AM
Lifshitz & Miller LLP Announces Investigation of Array BioPharma Inc., C&J Energy Services, Inc., Liberty Expedia Holdings, Inc., and Raytheon Company, Shutterfly, Inc., Sotheby's and Stewardship Financial Corporation, and Zimmer Biomet Holdings, Inc.
PRNewswire 27-Jun 12:01 PM
Array BioPharma to Present Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E- Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer
PRNewswire 25-Jun 8:00 AM
PRNewswire 21-Jun 8:00 PM
PRNewswire 18-Jun 5:57 PM
Globe Newswire 17-Jun 6:14 PM
Globe Newswire 17-Jun 10:30 AM
Business Wire 17-Jun 6:45 AM
PRNewswire 4-Jun 4:05 PM
PRNewswire 29-May 11:55 AM
Featured Article 20-Jun 1:13 PM
Stock Price | Full Chart
|Correlated Symbol||Name||Sector||R-Squared||Beta||Current Price||% Chg|
This correlation is calculated using one year's worth of weekly returns.
An R-Squared of 1.00 is the maximum value. Beta is only significant when the R-Squared is a high value.